跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Anti-fibrotic agent
首页
药物
Anti-fibrotic agent
Anti-fibrotic agent
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
INCREASING CANCER CELLS' SENSITIVITY TO TUMOR TREATING FIELDS (TTFIELDS) BY INHIBITING FIBROSIS WITH A CALCIUM CHANNEL BLOCKER
EP 4009971 C0
申请人: NOVOCURE GMBH
优先权: 2019
CN
EP
US
WO
13 件公开
Polymer compositions and methods for their use
US 2005208095 A1
申请人: ANGIOTECH INT AG
优先权: 2004
US
11 件公开
METHODS FOR TREATING FIBROTIC CANCERS
EP 3718558 A1
申请人: PROMEDIOR INC
优先权: 2013
CN
EP
US
4 件公开
COMBINATION OF ELAFIBRANOR WITH AN ANTI-NASH, ANTI-FIBROTIC OR ANTI-CHOLESTATIC AGENT
EP 3612175 C0
申请人: GENFIT
优先权: 2017
EP
US
WO
4 件公开
COMBINATION OF AN AZETIDINE LPA1 RECEPTOR ANTAGONIST WITH PIRFENIDONE AND/OR NINTEDANIB FOR USE IN THE TREATMENT OF FIBROTIC DISEASES
EP 4069227 A1
申请人: IDORSIA PHARMACEUTICALS LTD
优先权: 2019
EP
US
WO
4 件公开
Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds
US 9072729 B2
申请人: ZHUO LANG
优先权: 2009
CN
US
3 件公开
Use of sphingosine 1-phosphate as active ingredient for the treatment of pulmonary fibrosis
US 7151093 B2
申请人: ONO PHARMACEUTICAL CO
优先权: 2003
US
3 件公开
Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions
US 9738581 B2
申请人: UNIV HONG KONG BAPTIST UNIV
优先权: 2016
US
3 件公开
TREATMENT OF FIBROSIS
US 2008159995 A1
申请人: SPITERI MONICA SILVERSTONE
优先权: 2007
CN
US
2 件公开
Anti-marinobufagenin antibodies and uses thereof
US 10654925 B2
申请人: CTS BIOPHARMA LLC
优先权: 2018
CN
US
2 件公开
第 1 / 4 页
上一页
下一页
药物
反馈